Daniel Alders expresses gratitude for Hill Country community support in recent tweets

Daniel Alders expresses gratitude for Hill Country community support in recent tweets
Daniel Alders, Texas State Representative from the 6th district — Official Website
0Comments

Daniel Alders, an active social media user, recently shared a series of posts expressing gratitude and highlighting the resilience of his community in Texas. The tweets reflect appreciation for local support and acknowledgment of the strength demonstrated by Texans during challenging times.

On July 12, 2025, Alders posted a message thanking supporters and referencing the Hill Country region: “Amazing support. Thank you to all who are #HillCountryStrong”.

The following day, on July 13, 2025, Alders shared a tweet containing only a link: “https://t.co/zqSUpTmgvl”.

Later on July 13, 2025, Alders expressed appreciation for the faith and perseverance of Texans facing adversity: “Thankful for the testimony of so many amazing Texans whose faith is strong, even in grief.”

Additional information for Step 3: The Hill Country is a geographic region located in Central Texas known for its unique landscape and tight-knit communities.



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

Cities located in Van Zandt County saw FDA inspections of 3 companies in 2025

There were three companies in cities associated with Van Zandt County that received three FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Benjamin D. Moncarz Chief Financial Officer - FDA

Smith County cities: 11 companies received FDA inspections in 2025

There were 11 companies in a city associated with Smith County that received 11 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sean R. Keveney J.D., Chief Counsel of FDA

FDA conducted inspections of 3 companies in cities located in Cherokee County in 2025

There were three companies in a city associated with Cherokee County that received three FDA inspections in 2025, according to the U.S. Food and Drug Administration.